Fresenius Kabi
Angelos M. currently holds the position of Junior Manager Financial Disclosures & Analytics at Fresenius Kabi, where responsibilities include dashboarding, reporting, scenario simulations, and data-driven decision making. Concurrently serving as a Lecturer & Scientific Supervisor at Baden-Wuerttemberg Cooperative State University (DHBW), Angelos M. conducts training sessions on LaTeX and supervises IT/project management projects. Previous experience includes a role as SAP S/4HANA Finance Consultant at IBM, providing support for migration projects, and a series of cooperative education positions at Fresenius Medical Care and Fresenius Digital Technology, focusing on market analysis, data governance, and internal auditing. Academic credentials include a Bachelor of Science in Business Information Systems - E-Health from DHBW.
This person is not in any teams
This person is not in any offices
Fresenius Kabi
16 followers
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.